SITC:NYSESITE Centers Corp. Analysis
Data as of 2026-06-01 - not real-time
$5.05
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
SITE Centers trades around $5.05, well below its DCF‑derived fair value of roughly $14.5, implying an upside of nearly 80 % and positioning the stock as deeply undervalued. Technical signals are mixed: the 20‑day and 50‑day SMAs are virtually flat at $5.43, the RSI sits at 29 suggesting oversold conditions, while the MACD histogram is negative and the overall trend is neutral. Volume is increasing, providing some support for a potential bounce toward the $5.70 resistance level. Recent material news includes the announcement of the Meadowmont Crossing sale, which could bolster cash flow, and Piper Sandler’s raised price target with a neutral outlook, reinforcing the valuation thesis. On the fundamentals side, the company carries no debt, holds $193 M in cash, and boasts a book‑value per share of $6.38, yet revenue has plunged by nearly 70 % and operating margins are negative, highlighting earnings volatility. Despite a trailing PE of 1.5, the forward PE is deeply negative, reflecting the current earnings weakness. The REIT’s dividend is currently zero, so income‑focused investors will not receive yield. Overall, the stock’s low price relative to intrinsic value, strong balance sheet, and technical oversold signals create a compelling case for upside, but the sharp revenue decline and negative operating performance temper enthusiasm.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- RSI indicating oversold conditions
- Price near strong support at $5.04
- Significant DCF upside potential
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Negative operating margin and steep revenue decline
- Zero dividend limiting income appeal
- Increasing volume suggesting market interest
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Zero debt and ample cash reserves
- Potential rent growth as retail spaces stabilize
- Undervalued valuation multiples relative to industry peers
Key Metrics & Analysis
Financial Health
Revenue Growth-69.80%
Profit Margin188.67%
P/E Ratio1.5
ROE41.08%
ROA-1.54%
P/B Ratio0.8
Op. Cash Flow$9.6M
Free Cash Flow$42.9M
Industry P/E32.3
Technical Analysis
TrendNeutral
RSI29.5
Support$5.04
Resistance$5.70
MA 20$5.43
MA 50$5.43
MA 200$7.12
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$14.50
Target Price$6.00
Upside/Downside18.81%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.95
Volatility24.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.